Are There Better or Complementary Alternatives
Identify gaps in the literature and ongoing research directions Key gaps include a lack of large, controlled clinical trials, unclear optimal dosing and delivery for reproductive targets, limited long-term safety data for systemic use, and few mechanistic human studies linking molecular changes to fertility outcomes
Follow standard laboratory storage practices appropriate for research materials to help maintain integrity over time
It is vital to use these peptides under professional guidance and in combination with other supportive therapies
Clinical Update 3/05/2024 Sweeteners for Keto Diet See which sweeteners are our Top Picks for those on a low-carb or ketogenic diet
The FDA has classified BPC-157 in Category 2 for bulk drug substances, citing possible safety issues in compounding, such as immunogenicity, impurities, and insufficient safety evidence for suggested administration routes